SCHEMBL8268508

SCHEMBL8268508

O=C(Nc1ccc(Cl)cc1)N[C@H](CS)C(=O)Nc1ccc(N2CCOCC2=O)cc1

nearest known ligand 0.82

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ F10 P00742 18/20 0.82
▸ PTGS2 P35354 1/20 0.50
▸ MAPT P10636 1/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13677854 0.90 F10 (0.82) F10PTGS2MAPTSMN1; SMN2
SCHEMBL13677849 0.89 F10 (0.81) F10PTGS2MAPTSMN1; SMN2
SCHEMBL13890614 0.89 F10 (0.79) F10PTGS2
SCHEMBL1406012 0.88 F10 (0.78) F10PTGS2
SCHEMBL13677852 0.88 F10 (0.78) F10PTGS2
SCHEMBL1406066 0.88 F10 (0.78) F10PTGS2
SCHEMBL1406068 0.88 F10 (0.81) F10PTGS2
SCHEMBL13677848 0.88 F10 (0.78) F10PTGS2
SCHEMBL6373383 0.87 F10 (0.77) F10PTGS2
SCHEMBL1405981 0.87 F10 (0.77) F10PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7598241-B2 2-[3-(4-chlorophenyl)ureido] N-[4-(2-oxo-2H-pyridin-1-yl)phenyl]-4-methanesulfonylbutyramide; prophylaxis and/or therapy of thromboembolic diseases and for the treatment of tumors MERCK PATENT GMBH (DE) 2009-10-06 — — US disclosed
US-7598241-B2 2-[3-(4-chlorophenyl)ureido] N-[4-(2-oxo-2H-pyridin-1-yl)phenyl]-4-methanesulfonylbutyramide; prophylaxis and/or therapy of thromboembolic diseases and for the treatment of tumors MERCK PATENT GMBH (DE) 2009-10-06 — — US disclosed
WO-2006032342-A2 CARBONYL COMPOUND-CONTAINING DRUG AND THE USE THEREOF MERCK PATENT GMBH (DE) 2006-03-30 — — WO disclosed
Send feedback